Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH

被引:16
作者
Babicka, Libuse [1 ]
Ransdorfova, Sarka
Brezinova, Jana
Zemanova, Zuzana
Sindelarova, Lenka
Siskova, Magda
Maaloufova, Jacqueline
Cermak, Jaroslav
Michalova, Kyra
机构
[1] Gen Fac Hosp, Ctr Oncocytogenet, Inst Clin Biochem & Lab Diagnost, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[3] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic
[4] Gen Fac Hosp, Dept Med 1, Prague, Czech Republic
关键词
MDS; AML; complex chromosomal aberrations; mFISH; mBAND;
D O I
10.1016/j.leukres.2006.03.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analyzed complex chromosomal aberrations in 37 adult patients with myclodysplastic syndrome (MDS) and acute myeloid leukemia (AML) using classical cytogenetic method, FISH with locus-specific probes, multicolor FISH (mFISH) and multicolor banding (mBAND). Unbalanced structural aberrations, leading to a gain or loss of chromosomal material, were frequently observed in bone marrow cells. In 30 patients (81.1%) loss or rearrangement of chromosome 5, 7 and/or I I was found. The most frequent numerical change was trisomy 8 as expected (detected in six patients-16.2%) and the most frequent breakpoints 5q 13, 5q33, 7q3 1, 10p12, 11q23, 12p13, 17p11 and 21q22 were determined. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 46 条
  • [1] Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel
    Alvarez, S
    Cigudosa, JC
    [J]. HEMATOLOGICAL ONCOLOGY, 2005, 23 (01) : 18 - 25
  • [2] Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents
    Andersen, MK
    Christiansen, DH
    Kirchhoff, M
    Pedersen-Bjergaard, J
    [J]. GENES CHROMOSOMES & CANCER, 2001, 31 (01) : 33 - 41
  • [3] THE CLINICAL-SIGNIFICANCE OF KARYOTYPE IN ACUTE MYELOGENOUS LEUKEMIA
    ARTHUR, DC
    BERGER, R
    GOLOMB, HM
    SWANSBURY, GJ
    REEVES, BR
    ALIMENA, G
    VANDENBERGHE, H
    BLOOMFIELD, CD
    DELACHAPELLE, A
    DEWALD, GW
    GARSON, OM
    HAGEMEIJER, A
    KANEKO, Y
    MITELMAN, F
    PIERRE, RV
    RUUTU, T
    SAKURAI, M
    LAWLER, SD
    ROWLEY, JD
    [J]. CANCER GENETICS AND CYTOGENETICS, 1989, 40 (02) : 203 - 216
  • [4] Role of multiplex FISH in identifying chromosome involvement in myelodysplastic syndromes and acute myeloid leukemias with complex karyotypes:: a report on 28 cases
    Barouk-Simonet, E
    Soenen-Cornu, V
    Roumier, C
    Cosson, A
    Laï, JL
    Fenaux, P
    Preudhomme, C
    [J]. CANCER GENETICS AND CYTOGENETICS, 2005, 157 (02) : 118 - 126
  • [5] PROGNOSTIC-SIGNIFICANCE OF CHROMOSOMAL-ABNORMALITIES IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A STUDY OF 343 PATIENTS
    BERGER, R
    BERNHEIM, A
    OCHOANOGUERA, ME
    DANIEL, MT
    VALENSI, F
    SIGAUX, F
    FLANDRIN, G
    BOIRON, M
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 28 (02) : 293 - 299
  • [6] Bloomfield CD, 1997, CANCER-AM CANCER SOC, V80, P2191
  • [7] Bloomfield CD, 1998, CANCER RES, V58, P4173
  • [8] THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA ASSOCIATED WITH 11Q23 CHROMOSOMAL-ABNORMALITIES AND TOPOISOMERASE-II INHIBITORS - REPORT OF 4 ADDITIONAL CASES AND BRIEF COMMENTARY
    BREDESON, CN
    BARNETT, MJ
    HORSMAN, DE
    DALAL, BI
    RAGAZ, J
    PHILLIPS, GL
    [J]. LEUKEMIA & LYMPHOMA, 1993, 11 (1-2) : 141 - 145
  • [9] Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms
    Castro, PD
    Liang, JC
    Nagarajan, L
    [J]. BLOOD, 2000, 95 (06) : 2138 - 2143
  • [10] Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis
    Christiansen, DH
    Andersen, MK
    Pedersen-Bjergaard, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1405 - 1413